Chutian Technology Co., Ltd., one of the top ten brands of pharmaceutical equipment, a famous trademark in Hunan Province, an overall solution provider of intelligent medical equipment, and a leading enterprise of domestic aqueous pharmaceutical equipment

Founded in 2000, Truking Technology Co., Ltd. has become one of the world's leading enterprises in the medical equipment industry after 17 years of development. The main business is the overall solution of intelligent medical equipment, and takes the lead in promoting the research and development of smart pharmaceutical factories. Headquartered in Changsha, China, the company has headquarters assets of about 2.9 billion yuan, a total market value of 7.5 billion yuan, a factory covering an area of more than 400 acres, a total of more than 2,000 employees, and annual sales of more than 1.5 billion. The company is an A-share listed company in China, stock name: Chutian Technology, stock code: 300358. It has a number of wholly-owned or holding subsidiaries such as Truking Huatong, Sichuan Pharmaceutical Design Institute, and Truking Intelligent Robot. In April 2017, the company spent more than 1.1 billion yuan to acquire the world-famous medical equipment company Normac Group of Germany, and its industry status jumped to the world's first-class, including the world's largest output and the world's largest factory scale. After the consolidated financial statements, the company's total assets are 4 billion yuan, the annual revenue is more than 30 billion yuan, and the total number of employees is more than 3,000 people. The company has two major operation headquarters in Changsha and Germany, and has three R&D institutions: German Institute of Technology, Changsha Central Institute of Technology and Shanghai Institute of Technology. It has a number of technology and innovation platforms such as a national enterprise technology center, a national innovation base, a postdoctoral research workstation, and an academician expert workstation. As of April 30, 2017, a total of 2,219 Chinese patent applications (including 549 invention patent applications) have been submitted, and 1,389 authorized patents (including 236 invention patents) have been submitted. In addition, 25 PCT international patent applications were filed, and 11 patents were granted in the United States, Japan, Russia, and India. The products have been exported to more than 30 countries and regions in Asia, Europe, South America and the former Soviet Union, and the international market share is increasing rapidly year by year.

While adhering to the established business areas, the company will also enter the field of high-end medical devices and pharmaceuticals and medical robots in a big way in recent years, promote the development of medical equipment and medical devices, and lay out great health. The company adheres to the core values of "being a respected person, creating a respected product, and running a respected enterprise", adheres to the concept of "either the only or the first", carries forward the spirit of "excellence because of perseverance", and builds and realizes the dream of 2025: annual revenue of 20 billion yuan, total market value of 100 billion yuan, a new leader in global medical equipment, and makes important contributions to the cause of human health.